On November 20, 2024, Mr. Shunichiro Kurita, Senior Manager of Health and Global Policy Institute (HGPI), will give a lecture at the third part of Innovation for NEW HOPE Symposium titled advancing diagnosis and treatment for Intractable Diseases: Building a Supportive Community for All.

Innovation for NEW HOPE is a project launched in August 2023 by six individuals with shared aspirations, including patient groups and medical professionals. The aim is to ‘realize a society where cutting-edge treatments are delivered as quickly and continuously as possible in Japan.’ This symposium seeks to foster a society where patients and their families can live more comfortably by raising public awareness of the current situation regarding intractable diseases and highlighting the importance of early diagnosis and access to treatment.

Mr. Kurita will be speaking in the following program.
・Session 3 “Patient and Community Perspectives on Future Approaches to Intractable Diseases”

Further information available here
* Japanese only

[Event Overview]

• Date & Time: Wednesday, November 20, 2024; 14:30 – 16:10 JST (Door open at 14:00)
• Format: Hybrid (on-site/online)
• Venue: Meeting room A at Nihonbashi Life Science Hub (8th Floor, Muromachi Chibagin Mitsui Building, 1-5-5 Nihonbashi Muromachi, Chuo-ku, Tokyo. 103-0022)
• Language: Japanese
• Participation fee: Free
• Organizer: Innovation for NEW HOPE
• Operation: Astellas Pharma Inc.
• Cooperation: Alexion Pharmaceuticals, Inc., Blue Lab Co., LTD., HGPI